Volume 69, Issue 1, Pages e3 (January 2018)

Slides:



Advertisements
Similar presentations
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Advertisements

Fabien Darfeuille, Cecilia Unoson, Jörg Vogel, E. Gerhart H. Wagner 
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 67, Issue 1, Pages e3 (July 2017)
Structural Changes in TAF4b-TFIID Correlate with Promoter Selectivity
Andrei Alexandrov, Mei-Di Shu, Joan A. Steitz  Molecular Cell 
Chaoyou Xue, Natalie R. Whitis, Dipali G. Sashital  Molecular Cell 
Global Mapping of Human RNA-RNA Interactions
Volume 154, Issue 2, Pages (July 2013)
Xue Q. Gong, Chunfen Zhang, Michael Feig, Zachary F. Burton 
Volume 63, Issue 5, Pages (September 2016)
Lu Bai, Andrej Ondracka, Frederick R. Cross  Molecular Cell 
Volume 68, Issue 4, Pages e5 (November 2017)
Volume 54, Issue 4, Pages (May 2014)
Volume 58, Issue 1, Pages (April 2015)
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
Volume 62, Issue 1, Pages (April 2016)
A Massively Parallel Reporter Assay of 3′ UTR Sequences Identifies In Vivo Rules for mRNA Degradation  Michal Rabani, Lindsey Pieper, Guo-Liang Chew,
Volume 55, Issue 2, Pages (July 2014)
The Translational Landscape of the Mammalian Cell Cycle
Volume 65, Issue 1, Pages (January 2017)
m6A Facilitates eIF4F-Independent mRNA Translation
Volume 38, Issue 1, Pages (April 2010)
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
Therapeutic editing of hepatocyte genome in vivo
Hiro-oki Iwakawa, Yukihide Tomari  Molecular Cell 
Fabien Darfeuille, Cecilia Unoson, Jörg Vogel, E. Gerhart H. Wagner 
Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
Volume 22, Issue 3, Pages e3 (September 2017)
Volume 164, Issue 1, Pages (January 2016)
A Solution to Limited Genomic Capacity: Using Adaptable Binding Surfaces to Assemble the Functional HIV Rev Oligomer on RNA  Matthew D. Daugherty, Iván.
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Mechanism of Bidirectional Leading-Strand Synthesis Establishment at Eukaryotic DNA Replication Origins  Valentina Aria, Joseph T.P. Yeeles  Molecular.
Andrew R. Bassett, Charlotte Tibbit, Chris P. Ponting, Ji-Long Liu 
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis  Beth A. Rousseau, Zhonggang Hou, Max J. Gramelspacher,
Crystal Structure of a Y-Family DNA Polymerase in Action
Volume 69, Issue 5, Pages e5 (March 2018)
Volume 63, Issue 4, Pages (August 2016)
Volume 69, Issue 5, Pages e7 (March 2018)
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
LexA Cleavage Is Required for CTX Prophage Induction
Volume 132, Issue 6, Pages (March 2008)
Volume 25, Issue 1, Pages (January 2017)
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Volume 24, Issue 3, Pages (November 2006)
Hayun Lee, Yi Zhou, David W. Taylor, Dipali G. Sashital  Molecular Cell 
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
Volume 67, Issue 6, Pages e9 (September 2017)
Volume 52, Issue 3, Pages (November 2013)
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Insights into Branch Nucleophile Positioning and Activation from an Orthogonal Pre- mRNA Splicing System in Yeast  Duncan J. Smith, Maria M. Konarska,
Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii. Tagging of the endogenous Py03652 gene with the gfp gene in Plasmodium yoelii.
Hui Yang, Dinshaw J. Patel  Molecular Cell 
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
Ciaran M Lee, Thomas J Cradick, Gang Bao  Molecular Therapy 
Fig. 3 AcrIIA4 inhibits DNA cleavage in vitro.
Volume 16, Issue 2, Pages (February 2015)
Volume 30, Issue 3, Pages (May 2008)
Volume 41, Issue 2, Pages (January 2011)
The Biology of CRISPR-Cas: Backward and Forward
Adaptation in CRISPR-Cas Systems
Volume 16, Issue 11, Pages (September 2016)
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
CRISPR Immunological Memory Requires a Host Factor for Specificity
Systematic Study of Nucleosome-Displacing Factors in Budding Yeast
Volume 25, Issue 4, Pages e3 (October 2018)
Presentation transcript:

Volume 69, Issue 1, Pages 146-157.e3 (January 2018) Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell- Free Transcription-Translation System  Ryan Marshall, Colin S. Maxwell, Scott P. Collins, Thomas Jacobsen, Michelle L. Luo, Matthew B. Begemann, Benjamin N. Gray, Emma January, Anna Singer, Yonghua He, Chase L. Beisel, Vincent Noireaux  Molecular Cell  Volume 69, Issue 1, Pages 146-157.e3 (January 2018) DOI: 10.1016/j.molcel.2017.12.007 Copyright © 2017 Elsevier Inc. Terms and Conditions

Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 S. pyogenes Cas9 Functions Efficiently in TXTL (A) Schematic of using TXTL to dynamically and quantitatively measure the activity of Cas9 and dCas9. (B) Time series showing deGFP concentration for cell-free reactions expressing (d)Cas9 and a non-targeting sgRNA (green) or targeting sgRNAs (blue). Target locations include the sequence matching the guide (blue line) and the PAM (yellow circle). Error bars represent the SEM from at least six repeats. (C) Alternative sigma factors σ28, σ38, and σ54 and the T7 polymerase can be expressed in TXTL from the P70a promoter and activate their cognate promoters P28a, P38a, P54a, and PT7, respectively. A matrix showing dSpyCas9-based repression of promoters dependent on σ28, σ38, σ54, and the T7 polymerase is shown. An sgRNA targeting each promoter or the gfp gene body was expressed along with each sigma factor or polymerase and a reporter gene driven by the sigma factor of its cognate promoter. Values represent the mean of at least three repeats. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Multiple Factors Affect dSpyCas9-Based Repression of Reporter Gene Expression in TXTL (A) Fold repression produced by a TXTL reaction when deGFP is expressed from either a targeted plasmid (dark) or linear (light) construct. Error bars represent the SEM from at least three repeats. (B) Time series showing deGFP concentration in TXTL for cell-free reactions expressing dSpyCas9 and a targeting sgRNA. The reporter plasmid is added to the reaction either at the same time as dSpyCas9 and the sgRNA (top row) or after 3 hr (bottom row). Error bars represent the SEM from at least five repeats. (C) Time to repression for the curves from (B), as well as for “dSpyCas9 pre-pack.” Error bars represent the SEM from at least five repeats. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 TXTL Can Be Used to Assess the Activity of sgRNAs (A) A schematic of where each guide binds in the gfp promoter and gene body (top). The location of the target and PAM is indicated by a blue line and a yellow or orange dot, respectively. The fold repression of GFP production by dCas9-based repression for each sgRNA in vivo and in vitro (bottom). Points are colored by whether the guide is adjacent to an NGG (yellow) or NAG (orange) PAM, and whether the sgRNA targets the non-template strand (black ring) or template strand (gray ring). Error bars represent the SEM from at least three repeats. (B) Assessing non-gfp targeting sgRNAs used by dCas9. The sequence or gene of interest is transcriptionally or translationally fused upstream of degfp. Fold repression was measured in TXTL for four targeting sgRNAs when degfp is fused to mscL or hla. Error bars represent the SEM from at least three repeats. (C) Assessing non-gfp targeting sgRNAs used by Cas9. The sequence or gene of interest was inserted upstream of the promoter driving expression of deGFP. In the absence of a RecBCD inhibitor, cleavage by Cas9 leads to rapid degradation of the plasmid and loss of GFP expression. Fold repression was measured in TXTL when targeting in the gfp coding sequence (sg8) or upstream of the promoter (sg8) with Cas9 or dCas9, and in the presence or absence of the RecBCD inhibitor Chi site containing DNA. Error bars represent the SEM from at least three repeats. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 Single Effector and Multi-protein Effector Cas Proteins Function Efficiently in TXTL (A and B) Time series of reporter gene expression in TXTL for cell-free reactions expressing (A) a catalytically inactive version of the Type V-A Cpf1 nuclease from Francisella novicida or (B) the Type I-E Cascade complex from E. coli. The protein or set of proteins was expressed along with a non-targeting gRNA (green) or one of three gRNAs (blue) designed to target the promoter of the deGFP reporter construct. The reporter plasmid is added to the reaction either at the same time as the constructs expressing the Cas protein(s) and the gRNA (top row) or after 3 hr (bottom row). Error bars represent the SEM from six repeats. (C) Time to repression for the curves from (A), as well as for “dFnCpf1 pre-pack.” Error bars represent the SEM from at least five repeats. (D) Time to repression for the curves from (B). Error bars represent the SEM from at least four repeats. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 5 TXTL Can Be Used to Rapidly Characterize Anti-CRISPR Proteins (A) Time series of deGFP-ssrA expression in TXTL for cell-free reactions also expressing dSpyCas9, an sgRNA, and one of two anti-CRISPR proteins, AcrIIA2 and AcrIIA4, shown to inhibit SpyCas9 activity. Each reaction was performed with a targeting sgRNA (blue) or a non-targeting sgRNA (green). Error bars represent the SEM from at least three repeats. (B) A matrix showing the percentage inhibition for 24 different anti-CRISPR proteins on five different Cas9. Samples with no appreciable GFP expression in the presence of the anti-CRISPR protein are designated with light red. Values represent the mean of at least three technical replicates. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 6 TXTL Can Be Used to Determine CRISPR PAMs (A) Schematic of a TXTL-based cleavage assay to determine the PAM sequences recognized by Cas nucleases. (B) Plots showing the fold change in the representation of a nucleotide at each variable position in the PAM library as a result of FnCpf1 activity in comparison to the original PAM library. Note that the y axis is inverted to highlight nucleotides that are depleted. (C) Time series showing the depletion of selected motifs by FnCpf1 matching the consensus sequence in the sequencing libraries is shown. Error bars show the SD of the fold change. (D) A PAM wheel showing the determined PAM sequences recognized by FnCpf1. PAM sequences are read proceeding from the outside to the inside of the circle, and the arc length directly correlates with the extent of PAM depletion. The −5 position was not shown for clarity. (E) Plots showing the fold change in the representation of a nucleotide at each variable position in the PAM library in comparison to the original PAM library (top) and PAM wheels showing the determined PAM sequences (bottom) for five uncharacterized Cpf1 nucleases. A sixth Cpf1 nuclease (MbCpf1) previously characterized in Zetsche et al. (2015) is also reported in Figure S5. Molecular Cell 2018 69, 146-157.e3DOI: (10.1016/j.molcel.2017.12.007) Copyright © 2017 Elsevier Inc. Terms and Conditions